Discuss, Deploy, or Defer: New Technologies in Real World Biopharmaceutical Manufacturing
Jeff Baker – Deputy Director, Office of Biotechnology Products, FDA
Building Out a Novel RNAi Pipeline in an Accelerated Timeline: From Rare Disease to COVID-19
John Maraganore – CEO, Alnylam Pharmaceuticals
Utilize our networking app to view the entire attendee list, request and schedule meetings, host presentation materials and content assets, watch the full recording post-event, and access prior, during, and 60 days after the event. Learn more.
Panel Discussion: Accelerating R&D During a Pandemic – An Unprecedented Collaboration
Featuring senior-level representatives from Alnylam, Amgen, Takeda & UCB
Fireside Chat with Michelle McMurry-Heath – President & CEO of BIO